Under the adept leadership of Margarita Howard, HX5 has carved out a significant niche in the competitive world of government
contracting. Since its establishment in 2004, HX5 has grown from a small
startup to an influential company with over 1,000 employees and a presence in 34 locations.
Margarita Howard, a service-disabled veteran, founded HX5 with a clear
vision and a strategic approach. Her background in the Air Force and...
Anavex Life Sciences., a biopharmaceutical company specializing in
treatments for neurodegenerative and neurodevelopmental disorders, has
announced encouraging preliminary data from its 48-week Phase 2 extension study
of ANAVEX®2-73 (blarcamesine) for Parkinson’s disease dementia. The study
demonstrated that patients exhibited consistent clinical improvements over the
48-week period.
In the recent open-label extension study,...
Anavex Life Sciences, a clinical-stage biopharmaceutical
company, has announced encouraging results from its 48-week Phase 2 extension
study of ANAVEX®2-73 (blarcamesine) in patients with Parkinson’s disease
dementia. This open-label study highlights significant improvements across
multiple efficacy endpoints, signaling a promising advance in treating
neurodegenerative disorders.
The study, designated as ANAVEX2-73-PDD-EP-001, assessed...